Good price  online

products details

Created with Pixso. Home Created with Pixso. Products Created with Pixso.
Gastrointestinal Cancer Treatment
Created with Pixso. Sorafenib Tosylate Tablets 0.2g 60 Tablets Box Multi Kinase RAF VEGFR PDGFR Inhibitor for HCC RCC DTC Targeted Therapy

Sorafenib Tosylate Tablets 0.2g 60 Tablets Box Multi Kinase RAF VEGFR PDGFR Inhibitor for HCC RCC DTC Targeted Therapy

Brand Name: Sichuan Kelun Pharmaceutical Co., Ltd.
Model Number: Sorafenib KL-20234069
MOQ: Negotiable
Price: Please contact a specialist WhatsApp:55342706
Delivery Time: Negotiable
Payment Terms: Western Union,MoneyGram,T/T
Detail Information
Place of Origin:
Chengdu, Sichuan, China
Certification:
NMPA/GMP
Packaging Details:
Negotiable
Supply Ability:
Negotiable
Highlight:

Multi Kinase RAF VEGFR Inhibitor

,

HCC RCC DTC Oral Therapy

,

BRAF CRAF VEGFR PDGFR Blockade

Product Description

Sorafenib Tosylate 0.2g x 60 Tablets

[Product Name]

Generic Name: Sorafenib Tosylate

Specification: 0.2g x 60 Tablets

[Active Ingredient]

Sorafenib Tosylate

[Indications]

1. Advanced HCC. 2. Advanced RCC after cytokine failure. 3. Radioactive iodine-refractory DTC.

[Mechanism of Action]

Multi-kinase inhibitor targeting CRAF, BRAF, V600E BRAF, c-KIT, FLT-3 and VEGFR-1/2/3, PDGFR-b. Dual anti-proliferative and anti-angiogenic activity.

[Dosage]

400mg (2 tablets) twice daily on empty stomach. Reduce to 400mg once daily or every other day for toxicity.

[Adverse Reactions]

Diarrhea, hand-foot skin reaction, fatigue, hypertension, rash, alopecia. Cardiac ischemia, hemorrhage, GI perforation, hepatic failure.

[Storage]

Store below 30C. Keep out of reach of children.

[Shelf Life]

24 months

Approval: H20234069